New Delhi, January 14: The Drugs Controller General of India (DCGI) headed Subject Expert Committee will on Friday review applications of SII and Bharat Biotech for Covishield and Covaxin vaccines for full market approval to the vaccines, said reports. Bharat Biotech had on Thursday announced that its 'Covaxin' was now a universal vaccine approved for both adults and children.

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)